First, many tumor antigens are also expressed in normal tissues to varying degrees, leading to the possibility of off-target toxicity in normal tissues while attacking tumor cells (20), e.g., the expression of NECTIN-4 in skin tissues explains ADC-associated rashes and itchy side effects. Here, NECTIN4 is linked to neoplasm.